Ian E Smith

Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial

Paul Ellis, Nazneen Rahman, Alexander Gutin, 2018, Nature Medicine.

Noninvasive Detection of HER2 Amplification with Plasma DNA Digital PCR

Alan Ashworth, A. Ashworth, H. Gevensleben, 2013, Clinical Cancer Research.

Prognostic value of Ki67 expression after short-term presurgical endocrine therapy for primary breast cancer.

Mitch Dowsett, Roger A'Hern, M. Dowsett, 2007, Journal of the National Cancer Institute.

Triple-negative breast cancer.

Jorge S Reis-Filho, W. Foulkes, J. Reis-Filho, 2010, The New England journal of medicine.

Cell filtration‐laser scanning cytometry for the characterisation of circulating breast cancer cells

Mitch Dowsett, Lila Zabaglo, M. Dowsett, 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group.

Jack Cuzick, Lisa McShane, Christos Sotiriou, 2011, Journal of the National Cancer Institute.

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.

E. Winer, G. Hortobagyi, Baljit Singh, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Aromatase inhibitors in breast cancer.

Mitch Dowsett, M. Dowsett, I. Smith, 2003, The New England journal of medicine.

Proliferation marker Ki-67 in early breast cancer.

Mitch Dowsett, M. Dowsett, A. Urruticoechea, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The effect of the stromal component of breast tumours on prediction of clinical outcome using gene expression microarray analysis

Alan Mackay, Alan Ashworth, Mitch Dowsett, 2006, Breast Cancer Research.